Matches in SemOpenAlex for { <https://semopenalex.org/work/W1608739234> ?p ?o ?g. }
- W1608739234 endingPage "56" @default.
- W1608739234 startingPage "5848" @default.
- W1608739234 abstract "Emergence of the invasive phenotype is a key event in the progression of human melanoma from benign proliferative lesions to malignant lesions. Recently we successfully selected in vivo from a poorly metastatic M4Beu. human melanoma cell line two variants (7GP and T1P26) that generate a higher frequency of spontaneous metastases to the lungs into immune-suppressed neonatal rats. Both cell lines showed no significant differences in the integrin profile of the subunits analyzed except for beta3, which was reduced to a background level in metastatic variants. To investigate how these variant sublines of human melanomas manage to sustain growth in the absence of alpha(v)beta3, a subtractive immunization approach was used to elicit host antibody response against cell surface proteins expressed on metastatic variants. In this study, a new monoclonal antibody (MoAb), LY1, that is highly specific for the 7GP and T1P26 variants, was isolated. LY1 identifies a membrane protein of Mr 55,000 on melanoma variants with epitopes that were resistant to sugar-cleaving enzymes. Immunostaining cells from variants by LY1 showed that staining is distributed to the cell periphery with high labeling intensity at the cell-to-cell contact points. This MoAb significantly inhibited invasion of metastatic variants through a reconstituted basement membrane (Matrigel) in vitro. Moreover, tumor growth of melanoma variants was dramatically affected in vivo with this MoAb. In vitro studies indicate that the LY1 MoAb does not inhibit chemotactic migration of the metastatic variants, the adhesion of tumor cells to vitronectin, collagen IV, fibronectin, and laminin, or cell proliferation. Expression of this antigen is high in human striated muscle, heart, spleen, brain, and lung and absent in kidney, liver, and pancreas. Using 59 fixed, paraffin-embedded archival tissues of human melanomas and nevi, LY1-reactive cells were not observed in melanocytes, nevi, or radial growth phase primary melanomas. In sharp contrast, LY1 selectively stained melanocytes derived from the vertical growth phase of many primary melanomas and metastatic melanomas. These results provide evidence that the Mr 55,000 protein expressed by selected variants with increased metastatic properties in vivo plays a functionally important role in determining metastasis. This molecule may represent a new metastatic risk marker in human melanoma and may be of biological importance in the identification of fatal metastatic subpopulations that have acquired competence for metastasis production." @default.
- W1608739234 created "2016-06-24" @default.
- W1608739234 creator A5011472212 @default.
- W1608739234 creator A5020953238 @default.
- W1608739234 creator A5027949230 @default.
- W1608739234 creator A5029495254 @default.
- W1608739234 creator A5046931659 @default.
- W1608739234 creator A5055813274 @default.
- W1608739234 creator A5063310281 @default.
- W1608739234 creator A5065925736 @default.
- W1608739234 creator A5081297649 @default.
- W1608739234 date "2000-10-15" @default.
- W1608739234 modified "2023-10-18" @default.
- W1608739234 title "A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype." @default.
- W1608739234 cites W1510051502 @default.
- W1608739234 cites W1513691409 @default.
- W1608739234 cites W1577518201 @default.
- W1608739234 cites W1578124425 @default.
- W1608739234 cites W1606919584 @default.
- W1608739234 cites W1634520049 @default.
- W1608739234 cites W1938617858 @default.
- W1608739234 cites W1973642324 @default.
- W1608739234 cites W1975258154 @default.
- W1608739234 cites W1980029742 @default.
- W1608739234 cites W1981636060 @default.
- W1608739234 cites W1989247542 @default.
- W1608739234 cites W1994089726 @default.
- W1608739234 cites W1998225655 @default.
- W1608739234 cites W2002310626 @default.
- W1608739234 cites W2013296258 @default.
- W1608739234 cites W2018847450 @default.
- W1608739234 cites W2020579407 @default.
- W1608739234 cites W2021855589 @default.
- W1608739234 cites W2026151657 @default.
- W1608739234 cites W2028890259 @default.
- W1608739234 cites W2035211789 @default.
- W1608739234 cites W2043117244 @default.
- W1608739234 cites W2051587088 @default.
- W1608739234 cites W2054498037 @default.
- W1608739234 cites W2058418451 @default.
- W1608739234 cites W2060208069 @default.
- W1608739234 cites W2063858947 @default.
- W1608739234 cites W2075885982 @default.
- W1608739234 cites W2080057626 @default.
- W1608739234 cites W2085121809 @default.
- W1608739234 cites W2100837269 @default.
- W1608739234 cites W2108148222 @default.
- W1608739234 cites W2139666587 @default.
- W1608739234 cites W2149177848 @default.
- W1608739234 cites W2155044243 @default.
- W1608739234 cites W2230855630 @default.
- W1608739234 cites W2237585893 @default.
- W1608739234 cites W2328022154 @default.
- W1608739234 cites W2338174965 @default.
- W1608739234 cites W2344146347 @default.
- W1608739234 cites W2408791827 @default.
- W1608739234 cites W2414962566 @default.
- W1608739234 cites W2464269372 @default.
- W1608739234 cites W37222717 @default.
- W1608739234 cites W55114439 @default.
- W1608739234 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11059782" @default.
- W1608739234 hasPublicationYear "2000" @default.
- W1608739234 type Work @default.
- W1608739234 sameAs 1608739234 @default.
- W1608739234 citedByCount "9" @default.
- W1608739234 countsByYear W16087392342015 @default.
- W1608739234 crossrefType "journal-article" @default.
- W1608739234 hasAuthorship W1608739234A5011472212 @default.
- W1608739234 hasAuthorship W1608739234A5020953238 @default.
- W1608739234 hasAuthorship W1608739234A5027949230 @default.
- W1608739234 hasAuthorship W1608739234A5029495254 @default.
- W1608739234 hasAuthorship W1608739234A5046931659 @default.
- W1608739234 hasAuthorship W1608739234A5055813274 @default.
- W1608739234 hasAuthorship W1608739234A5063310281 @default.
- W1608739234 hasAuthorship W1608739234A5065925736 @default.
- W1608739234 hasAuthorship W1608739234A5081297649 @default.
- W1608739234 hasConcept C104317684 @default.
- W1608739234 hasConcept C127716648 @default.
- W1608739234 hasConcept C142724271 @default.
- W1608739234 hasConcept C1491633281 @default.
- W1608739234 hasConcept C150903083 @default.
- W1608739234 hasConcept C159654299 @default.
- W1608739234 hasConcept C164144092 @default.
- W1608739234 hasConcept C195616568 @default.
- W1608739234 hasConcept C203014093 @default.
- W1608739234 hasConcept C204232928 @default.
- W1608739234 hasConcept C207001950 @default.
- W1608739234 hasConcept C2777658100 @default.
- W1608739234 hasConcept C2778608917 @default.
- W1608739234 hasConcept C2779814568 @default.
- W1608739234 hasConcept C2780394083 @default.
- W1608739234 hasConcept C4224716 @default.
- W1608739234 hasConcept C502942594 @default.
- W1608739234 hasConcept C54355233 @default.
- W1608739234 hasConcept C55493867 @default.
- W1608739234 hasConcept C71924100 @default.
- W1608739234 hasConcept C81885089 @default.
- W1608739234 hasConcept C86492073 @default.